Hydroxyzine Dihydrochloride Premedication is a Necessity for Strabismus Surgery
Hydroxyzine Dihydrochloride Premedication is a Necessity for Pediatric Patients Undergoing Strabismus Surgery; An Observational Clinical Trial Controlled With Midazolam
Sponsor: Yeditepe University
Listed as NCT03806270, this observational or N/A phase trial focuses on Bradycardia Sinus and Hydroxyzine and remains completed. Sponsored by Yeditepe University, it has been updated 9 times since 2018, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 4 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2019 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Feb 2019 — Nov 2019 [monthly]
Recruiting
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yeditepe University
For direct contact, visit the study record on ClinicalTrials.gov .